Global Pertussis Vaccine Competitive Landscape Professional Research Report 2025

Global Pertussis Vaccine Competitive Landscape Professional Research Report 2025

Research Summary

The pertussis vaccine, commonly known as the whooping cough vaccine, is a vaccination aimed at preventing pertussis, a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It＇s often included in combination with vaccines for diphtheria and tetanus (DTaP vaccine for children) or in combination with tetanus and diphtheria for adults (Tdap vaccine). The vaccine stimulates the immune system to produce antibodies against the pertussis bacteria, offering protection against the disease. It＇s particularly vital for infants and young children, as pertussis can be severe and potentially life-threatening, especially in infants who have not completed the full vaccine series, and helps reduce the spread of the disease in the community.

According to DIResearch's in-depth investigation and research, the global Pertussis Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), MCM Vaccine, Merck, MassBiologics, Bionet-Asia, Amson Vaccines & Pharma, Serum Institute of India, Panacea Biotec, Kangtai Biological Products, Sino Biopharm, Chengdu Institute of Biological Products etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Pertussis Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pertussis Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pertussis Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pertussis Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Pertussis Vaccine Include:

Sanofi Pasteur

GSK

AJ Vaccines

KM Biologics (Meiji)

MCM Vaccine

Merck

MassBiologics

Bionet-Asia

Amson Vaccines & Pharma

Serum Institute of India

Panacea Biotec

Kangtai Biological Products

Sino Biopharm

Chengdu Institute of Biological Products

Pertussis Vaccine Product Segment Include:

Whole-cell Vaccines

Acellular Vaccines

Pertussis Vaccine Product Application Include:

12 Months Below

12 Months Above

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Pertussis Vaccine Industry PESTEL Analysis

Chapter 3: Global Pertussis Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Pertussis Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Pertussis Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Pertussis Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Pertussis Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources